Index
RUT
Market Cap
1.76B
Enterprise Value
1.28B
Income
-475.67M
Sales
68.23M
Book/sh
1.61
Cash/sh
0.89
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
600
IPO
Apr 16, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
25.81
P/B
1.75
P/C
3.16
P/FCF
-
EV/EBITDA
-
EV/Sales
18.75
Quick Ratio
5.01
Current Ratio
5.01
Debt/Eq
0.08
LT Debt/Eq
0.06
Option/Short
Yes / Yes
EPS (ttm)
-0.89
EPS next Y
-0.81
EPS next Q
-0.20
EPS this Y
38.90%
EPS next Y
7.67%
EPS next 5Y
19.33%
EPS past 3/5Y
-1.84% -22.39%
Sales past 3/5Y
23.30% 79.91%
EPS Y/Y TTM
50.69%
Sales Y/Y TTM
56.18%
EPS Q/Q
39.61%
Sales Q/Q
258.49%
Insider Own
10.15%
Insider Trans
-0.60%
Inst Own
59.25%
Inst Trans
3.06%
ROA
-36.29%
ROE
-48.72%
ROIC
-49.73%
Gross Margin
-39.97%
Oper. Margin
-725.44%
Profit Margin
-697.13%
SMA20
-21.60%
SMA50
-24.53%
SMA200
-18.26%
Trades
Shs Outstand
560.46M
Shs Float
560.07M
52W High
5.24 -46.09%
52W Low
2.50 13.00%
Volatility
9.55% 8.77%
ATR (14)
0.34
RSI (14)
35.91
Beta
1.25
Rel Volume
1.75
Avg Volume
23.58M
Volume
41,204,332
Perf Week
-21.31%
Perf Month
-22.81%
Perf Quarter
-15.42%
Perf Half Y
-4.56%
Perf YTD
-30.93%
Perf Year
-32.09%
Perf 3Y
-59.93%
Perf 5Y
-85.31%
Perf 10Y
-
Prev Close
2.72
Price
2.83
Change %
3.86%
Analysts 8 incl. previous ratings
Rating Distribution 4 Buy · 4 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Dec 17, 2025 Upgrade J JP Morgan
Neutral → Overweight $11 +289.4% Jul 03, 2025 Resumed M Morgan Stanley
Equal-Weight $5 +77.0% May 22, 2023 Initiated M Morgan Stanley
Equal-Weight $8 +183.2% Mar 16, 2023 Initiated N Needham
Buy $17 +501.8% Sep 16, 2022 Initiated K KeyBanc Capital Markets
Overweight $20 +608.0% Apr 18, 2022 Downgrade B BofA Securities
Buy → Neutral $10 +254.0% Mar 04, 2022 Downgrade S SVB Leerink
Outperform → Mkt Perform $10 +254.0% Sep 21, 2021 Initiated B Berenberg
Buy $37 +1,209.7% May 11, 2021 Initiated S SVB Leerink
Outperform $33 +1,068.1% May 11, 2021 Initiated K KeyBanc Capital Markets
Overweight $36 +1,174.3% May 11, 2021 Initiated J JP Morgan
Neutral $32 +1,032.7% May 11, 2021 Initiated G Goldman
Neutral $34 +1,103.5% May 11, 2021 Initiated B BofA Securities
Buy $31 +997.3%
Show Previous Ratings
Today 04:59AM
Nov-11-26 08:00AM
Nov-09-26 01:15PM
Nov-03-26 01:15PM
(Earnings Whispers)
-3.92%
Nov-02-26 11:37PM
(Associated Press)
-4.96%
04:30PM
Loading…
04:30PM
04:25PM
04:05PM
Oct-26-26 11:36PM
(Earnings Whispers)
+6.58%
04:05PM
Oct-16-26 12:10PM
Oct-15-26 01:59PM
08:45AM
08:30AM
08:22AM
09:23AM
Loading…
Oct-13-26 09:23AM
Oct-08-26 07:58PM
Oct-06-26 12:30PM
08:16AM
Sep-23-26 03:31PM
Sep-21-26 09:14AM
Aug-12-26 03:30PM
Aug-05-26 06:41AM
(Associated Press)
-4.23%
06:30AM
Aug-04-26 09:39AM
08:00AM
Jul-31-26 04:30PM
Jul-29-26 08:30AM
Jul-24-26 09:10AM
Jul-01-26 09:04AM
09:00AM
Loading…
09:00AM
Jun-30-26 09:00AM
Jun-16-26 08:45AM
Jun-15-26 02:48PM
Jun-02-26 08:00AM
May-29-26 04:30PM
(GlobeNewswire)
+4.36%
+5.57%
May-27-26 10:43AM
May-06-26 06:36AM
06:30AM
Apr-30-26 04:30PM
Apr-29-26 07:59AM
Apr-21-26 06:37AM
Apr-07-26 08:00AM
Mar-25-26 07:59AM
Mar-10-26 05:45PM
Mar-09-26 08:11PM
Mar-06-26 12:01PM
Feb-27-26 09:49AM
09:37AM
Feb-26-26 08:00PM
02:27PM
10:08AM
09:52AM
Feb-25-26 05:25PM
12:15PM
10:54AM
10:21AM
06:38AM
(Associated Press Finance)
06:30AM
Feb-24-26 03:52PM
07:25AM
Feb-23-26 02:47PM
10:33AM
09:07AM
08:00AM
07:55AM
Feb-20-26 05:45PM
10:01AM
Feb-19-26 05:10PM
04:47PM
11:14AM
05:27AM
Feb-18-26 05:50PM
04:40PM
02:07PM
01:21PM
09:37AM
(The Wall Street Journal)
08:30AM
05:43AM
Feb-17-26 04:58PM
09:48AM
Feb-12-26 10:00AM
07:59AM
Feb-10-26 05:45PM
Feb-04-26 05:50PM
Jan-29-26 05:50PM
09:25AM
06:15AM
Jan-28-26 09:21PM
Jan-24-26 03:35AM
Jan-23-26 05:50PM
Jan-20-26 10:14AM
Jan-18-26 12:30PM
Jan-16-26 05:05PM
Jan-15-26 05:50PM
Jan-08-26 05:50PM
Jan-07-26 08:20PM
Jan-06-26 07:59AM
Jan-02-26 03:22PM
09:10AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Borgeson Blake Director Nov 03 '26 Sale 3.88 40,000 155,200 6,068,287 Nov 04 05:12 PM Borgeson Blake Director Nov 03 '26 Proposed Sale 3.88 40,000 155,200 Nov 03 11:24 AM Borgeson Blake Director Oct 06 '26 Sale 4.84 50,000 242,000 6,108,287 Oct 07 06:08 PM HERSHBERG ROBERT Director Oct 06 '26 Option Exercise 2.22 25,000 55,500 187,156 Oct 07 06:08 PM HERSHBERG ROBERT Director Oct 06 '26 Sale 5.00 25,000 125,000 162,156 Oct 07 06:08 PM Borgeson Blake Director Oct 06 '26 Proposed Sale 4.84 50,000 242,000 Oct 06 11:48 AM HERSHBERG ROBERT Director Oct 06 '26 Proposed Sale 5.00 25,000 125,000 Oct 06 11:09 AM Khan Najat CEO and President Sep 08 '26 Sale 3.52 22,408 78,822 2,072,890 Sep 10 05:55 PM Najat Khan Officer Sep 08 '26 Proposed Sale 3.52 22,408 78,822 Sep 08 02:28 PM Borgeson Blake Director Sep 01 '26 Sale 3.34 30,000 100,200 6,158,287 Sep 02 06:01 PM Borgeson Blake Director Sep 01 '26 Proposed Sale 3.34 30,000 100,200 Sep 01 04:21 PM Gibson Christopher Former Director Aug 21 '26 Proposed Sale 3.39 77,290 262,013 Aug 21 11:27 AM Gibson Christopher Former Director Aug 20 '26 Proposed Sale 3.40 75,000 255,000 Aug 20 11:32 AM Gibson Christopher Former Director Aug 19 '26 Proposed Sale 3.27 100,000 327,500 Aug 19 11:54 AM Gibson Christopher Former Director Aug 18 '26 Proposed Sale 3.00 26,806 80,399 Aug 18 05:14 PM Gibson Christopher Former Director Aug 13 '26 Proposed Sale 3.31 100,000 331,000 Aug 13 12:58 PM Gibson Christopher Former Director Aug 12 '26 Proposed Sale 3.37 50,000 168,500 Aug 12 11:56 AM Gibson Christopher Former Director Aug 10 '26 Proposed Sale 3.27 100,000 326,754 Aug 10 04:59 PM Gibson Christopher Former Director Aug 07 '26 Proposed Sale 3.25 100,000 325,410 Aug 07 12:42 PM Borgeson Blake Director Aug 04 '26 Sale 3.25 30,000 97,500 6,188,287 Aug 06 05:09 PM Borgeson Blake Director Aug 04 '26 Proposed Sale 3.25 30,000 97,500 Aug 04 01:37 PM Gibson Christopher Former Director Aug 04 '26 Proposed Sale 3.27 75,000 244,875 Aug 04 10:35 AM Gibson Christopher Former Director Jul 30 '26 Proposed Sale 3.00 75,000 225,000 Jul 30 04:10 PM Gibson Christopher Former Director Jul 29 '26 Proposed Sale 3.03 50,000 151,372 Jul 29 04:09 PM Gibson Christopher Former Director Jul 27 '26 Proposed Sale 3.05 50,000 152,703 Jul 27 04:16 PM Gibson Christopher Former Director Jul 21 '26 Proposed Sale 3.04 100,000 304,263 Jul 21 04:11 PM Gibson Christopher Former Director Jul 20 '26 Proposed Sale 2.90 100,000 289,766 Jul 20 04:11 PM Gibson Christopher Former Director Jul 17 '26 Proposed Sale 2.97 100,000 296,726 Jul 17 04:10 PM Gibson Christopher Former Director Jul 16 '26 Proposed Sale 3.11 100,000 311,065 Jul 16 04:13 PM Gibson Christopher Former Director Jul 15 '26 Proposed Sale 3.33 123,334 410,283 Jul 15 04:12 PM Gibson Christopher Former Director Jul 14 '26 Proposed Sale 3.30 100,000 330,473 Jul 14 04:07 PM Gibson Christopher Former Director Jul 13 '26 Proposed Sale 3.43 100,000 343,048 Jul 13 04:32 PM Gibson Christopher Former Director Jul 10 '26 Proposed Sale 3.54 100,000 353,577 Jul 10 04:09 PM Borgeson Blake Director Jul 07 '26 Sale 3.96 40,000 158,500 6,218,287 Jul 09 06:04 PM Gibson Christopher Former Director Jul 09 '26 Proposed Sale 3.80 286,000 1,085,716 Jul 09 04:26 PM Gibson Christopher Former Director Jul 08 '26 Proposed Sale 3.69 200,000 737,694 Jul 08 04:26 PM Gibson Christopher Former Director Jul 07 '26 Proposed Sale 3.95 250,000 987,500 Jul 07 01:39 PM Borgeson Blake Director Jul 07 '26 Proposed Sale 3.96 40,000 158,500 Jul 07 11:36 AM Gibson Christopher Former Director Jul 06 '26 Proposed Sale 3.78 100,000 378,000 Jul 06 03:28 PM Gibson Christopher Former Director Jul 02 '26 Proposed Sale 3.75 100,000 374,500 Jul 02 12:54 PM Gibson Christopher Former Director Jul 01 '26 Proposed Sale 3.67 100,000 366,630 Jul 01 05:19 PM Bumpus Namandje Director Jun 18 '26 Sale 3.18 3,963 12,602 127,632 Jun 22 04:32 PM Gibson Christopher Director Jun 18 '26 Proposed Sale 3.20 300,440 962,341 Jun 18 04:33 PM Bumpus Namandje Director Jun 18 '26 Proposed Sale 3.18 3,963 12,602 Jun 18 09:44 AM Gibson Christopher Director Jun 18 '26 Proposed Sale 3.18 40,000 127,200 Jun 18 09:37 AM Gibson Christopher Director Jun 05 '26 Sale 3.62 40,000 144,800 883,735 Jun 05 05:03 PM Khan Najat CEO and President Jun 05 '26 Sale 3.58 23,588 84,459 2,175,796 Jun 05 05:02 PM Najat Khan Officer Jun 05 '26 Proposed Sale 3.58 23,588 84,459 Jun 05 01:29 PM Gibson Christopher Director Jun 05 '26 Proposed Sale 3.62 40,000 144,800 Jun 05 10:19 AM Bumpus Namandje Director Jun 03 '26 Sale 3.54 4,386 15,526 43,171 Jun 04 05:04 PM Borgeson Blake Director Jun 02 '26 Sale 3.68 30,000 110,400 6,169,863 Jun 04 05:04 PM Bumpus Namandje Director Jun 03 '26 Proposed Sale 3.54 4,386 15,526 Jun 03 10:16 AM Borgeson Blake Director Jun 02 '26 Proposed Sale 3.68 30,000 110,400 Jun 02 11:04 AM Gibson Christopher Director May 22 '26 Sale 3.08 40,000 123,200 883,735 May 27 04:15 PM Gibson Christopher Director May 22 '26 Proposed Sale 3.08 40,000 123,200 May 22 10:13 AM Gibson Christopher Director May 07 '26 Sale 3.37 40,000 134,800 926,556 May 08 04:59 PM Borgeson Blake Director May 05 '26 Sale 3.52 30,000 105,600 6,199,863 May 07 04:44 PM Gibson Christopher Director May 07 '26 Proposed Sale 3.37 40,000 134,800 May 07 11:13 AM Borgeson Blake Director May 05 '26 Proposed Sale 3.52 30,000 105,600 May 05 10:22 AM Gibson Christopher Director Apr 22 '26 Sale 3.61 40,000 144,400 906,556 Apr 24 04:23 PM Gibson Christopher Director Apr 22 '26 Proposed Sale 3.61 40,000 144,400 Apr 22 09:47 AM Gibson Christopher Director Apr 07 '26 Sale 3.10 40,000 124,000 906,556 Apr 08 04:58 PM Borgeson Blake Director Apr 07 '26 Sale 3.10 30,000 93,000 6,229,863 Apr 08 04:58 PM Gibson Christopher Director Apr 07 '26 Proposed Sale 3.10 40,000 124,000 Apr 07 10:46 AM Borgeson Blake Director Apr 07 '26 Proposed Sale 3.10 30,000 93,000 Apr 07 10:17 AM Gibson Christopher Director Mar 23 '26 Sale 3.25 40,000 130,000 906,556 Mar 25 04:36 PM Gibson Christopher Director Mar 23 '26 Proposed Sale 3.25 40,000 130,000 Mar 23 10:49 AM Taylor Ben R Chief Financial Officer Mar 17 '26 Sale 3.39 7,956 26,971 1,180,318 Mar 18 05:52 PM Taylor Ben R Officer Mar 17 '26 Proposed Sale 3.39 7,956 26,971 Mar 17 10:53 AM Khan Najat CEO and President Mar 09 '26 Sale 3.35 28,298 94,660 2,262,085 Mar 11 05:41 PM Najat Khan Officer Mar 09 '26 Proposed Sale 3.35 28,298 94,662 Mar 09 01:45 PM Borgeson Blake Director Mar 03 '26 Sale 3.46 170,000 588,200 6,259,863 Mar 04 04:38 PM Borgeson Blake Director Mar 03 '26 Proposed Sale 3.46 170,000 588,200 Mar 03 12:45 PM Gibson Christopher Director Feb 19 '26 Sale 3.46 40,000 138,400 906,556 Feb 19 07:30 PM Taylor Ben R Chief Financial Officer Feb 18 '26 Sale 3.08 13,426 41,352 1,195,349 Feb 19 07:30 PM Gibson Christopher Director Feb 19 '26 Proposed Sale 3.46 40,000 138,400 Feb 19 10:27 AM Taylor Ben R Officer Feb 18 '26 Proposed Sale 3.08 13,426 41,352 Feb 18 12:21 PM Gibson Christopher Director Feb 04 '26 Sale 4.12 40,000 164,800 913,839 Feb 06 05:53 PM Borgeson Blake Director Feb 03 '26 Sale 4.20 220,000 924,000 6,429,863 Feb 06 05:53 PM Gibson Christopher Director Feb 04 '26 Proposed Sale 4.12 40,000 164,800 Feb 04 09:50 AM Borgeson Blake Director Feb 03 '26 Proposed Sale 4.20 220,000 924,000 Feb 03 11:26 AM Gibson Christopher Director Jan 20 '26 Sale 4.47 40,000 178,800 913,839 Jan 22 07:34 PM Gibson Christopher Director Jan 20 '26 Proposed Sale 4.47 40,000 178,800 Jan 20 11:26 AM Borgeson Blake Director Jan 06 '26 Sale 4.36 220,000 959,200 6,649,863 Jan 08 05:01 PM Gibson Christopher Director Jan 05 '26 Sale 4.25 40,000 170,000 933,839 Jan 07 05:04 PM Borgeson Blake Director Jan 06 '26 Proposed Sale 4.36 220,000 959,200 Jan 06 09:40 AM Gibson Christopher Director Jan 05 '26 Proposed Sale 4.25 40,000 170,000 Jan 05 11:07 AM Taylor Ben R Chief Financial Officer Dec 29 '25 Sale 4.18 21,383 89,381 761,550 Dec 30 07:35 PM Khan Najat Chief R&D Commercial Officer Dec 22 '25 Sale 4.41 124,403 548,592 611,135 Dec 29 05:24 PM Taylor Ben R Officer Dec 29 '25 Proposed Sale 4.18 21,383 89,381 Dec 29 09:41 AM Najat Khan Officer Dec 22 '25 Proposed Sale 4.41 124,403 548,588 Dec 22 12:20 PM Gibson Christopher Chief Executive Officer Dec 19 '25 Sale 4.50 40,000 180,000 913,839 Dec 19 05:04 PM Gibson Christopher Officer Dec 19 '25 Proposed Sale 4.50 40,000 180,000 Dec 19 09:52 AM Gibson Christopher Chief Executive Officer Dec 04 '25 Sale 4.63 40,000 185,200 933,839 Dec 05 07:20 PM Borgeson Blake Director Dec 02 '25 Sale 4.37 220,000 961,400 6,869,863 Dec 04 04:51 PM Gibson Christopher Officer Dec 04 '25 Proposed Sale 4.63 40,000 185,200 Dec 04 10:01 AM Borgeson Blake Director Dec 02 '25 Proposed Sale 4.37 220,000 961,400 Dec 02 12:15 PM Gibson Christopher Chief Executive Officer Nov 19 '25 Sale 4.16 40,000 166,400 913,839 Nov 19 07:37 PM Gibson Christopher Officer Nov 19 '25 Proposed Sale 4.16 40,000 166,400 Nov 19 10:17 AM
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 4, 2013 and is headquartered in Salt Lake City, UT.
CEO Dr. Najat Khan Ph.D.
CFO & President of Recursion UK Mr. Ben R. Taylor
Chief Technology Officer Mr. Benjamin Mabey M.S.
Chief Scientific Officer Dr. David Hallett Ph.D.
M.B.A. Mr. Nathan Hatfield J.D.